Redwood City, CA, United States of America

Lars V Heumann

USPTO Granted Patents = 13 (Patent Applications = 5)

CIPO Patents = 2

EPO Patents = 9 (Patent Applications = 10)

Average Co-Inventor Count = 8.8

ph-index = 5

Forward Citations = 105(Granted Patents)

Location History:

Foster City, CA (US) (2017)
Redwood City, CA (US) (2014 - 2024)

Company Filing History:

6 out of 919

Gilead Sciences, Inc.

patents

3 out of 79

Gilead Pharmasset LLC

Leland Stanford Junior University

patents

5. 1 out of 1

Gillead Pharmasset LLC

patent

Years Active: 2014-2024

Loading Chart...

13 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 12030906 - Crystalline forms of (s)-2-ethylbutyl 2-(((s)-(((2r,3s,4r,5r)-5-(4-aminopyrrolo[2,1-f] [1,2,4]triazin-7-yl)-5-cyano-3,4-dihydroxytetrahydrofuran-2-yl)methoxy) (phenoxy) phosphoryl)amino)propanoate (2024-07-09),

2. 11760746 - Methods and intermediates for preparing therapeutic compounds (2023-09-19),

3. 11613553 - Methods of preparing 1'-cyano nucleosides (2023-03-28),

4. 11597742 - Crystalline forms of (S)-2-ethylbutyl 2-(((S)-(((2R,3S,4R,5R)-5-(4-aminopyrrolo[2,1-f] [1,2,4]triazin-7-yl)-5-cyano-3,4-dihydroxytetrahydrofuran-2-yl)methoxy) (phenoxy) phosphoryl)amino)propanoate (2023-03-07),

5. 11344565 - Methods for the preparation of ribosides (2022-05-31),

6. 11192875 - Processes for preparing antiviral compounds (2021-12-07),

7. 11046680 - Heteroaryl-substituted triazoles as APJ receptor agonists (2021-06-29),

8. 10836787 - Crystalline forms of (S)-2-ethylbutyl 2-(((S)-(((2R,3S,4R,5R)-5- (4-aminopyrrolo[2,1-f] [1,2,4]triazin-7-yl)-5-cyano-3,4-dihydroxytetrahydrofuran-2-yl)methoxy)(phenoxy) phosphoryl)amino)propanoate (2020-11-17),

9. 10736883 - Triazole furan compounds as agonists of the APJ receptor (2020-08-11),

10. 10584109 - Processes for preparing antiviral compounds (2020-03-10),

11. 9890134 - Processes for preparing antiviral compounds (2018-02-13),

12. 9670187 - Processes for preparing antiviral compounds (2017-06-06),

13. 8816122 - Prostratin analogs, bryostatin analogs, prodrugs, synthetic methods, and methods of use (2014-08-26),

Certainly! Here is the article about inventor Lars V Heumann:

Title: Unveiling the Innovations of Lars V Heumann in Redwood City, CA

Introduction: Meet Lars V Heumann, a prolific inventor based in Redwood City, CA, whose passion for innovation has led to the successful development of numerous patents in the realm of therapeutic compounds and nucleosides. With 12 patents to his name, Lars V Heumann is a prominent figure in the world of inventors.

Latest Patents: Lars V Heumann's recent patents showcase his expertise in the field, particularly in the preparation of therapeutic compounds and 1′-cyano nucleosides. His inventions include methods and intermediates for preparing therapeutic compounds, as well as methods for preparing 1′-cyano nucleosides from specific compounds. These patents highlight his dedication to advancing pharmaceutical research and development.

Career Highlights: Lars V Heumann has made significant contributions to renowned companies such as Gilead Sciences, Inc. and Gilead Pharmasset LLC. Through his innovative work, he has played a vital role in enhancing the pharmaceutical industry's capabilities and pushing the boundaries of scientific discovery. His tenure at these esteemed organizations underscores his commitment to driving progress and innovation.

Collaborations: During his career, Lars V Heumann has collaborated with notable individuals in the field, including Scott Alan Wolckenhauer and Kevin McCormack Allan. Together, they have worked on various projects, leveraging their collective expertise to achieve groundbreaking results in pharmaceutical research.

Conclusion: In conclusion, Lars V Heumann stands as a beacon of innovation in Redwood City, CA, with a remarkable portfolio of patents that have made a significant impact on the pharmaceutical industry. His dedication to excellence and collaborative spirit continue to inspire advancements in the field of therapeutic compounds.

This text is generated by artificial intelligence and may not be accurate.